Your Article Summary
Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients
Current Medical Research and Opinion, 06/30/09
Maffioli GDP et al. - Fenofibrate+simvastatin association improved lipid parameters, prothrombotic and inflammatory factors, and appeared to have a good tolerability profile over 12 months of therapy.
Today in Drug Interactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Acetazolamide and midazolam act synergistically to inhibit neuropathic pain
Pain, 12/16/09
Cyclosporine Versus Tacrolimus in Immunosuppressive Maintenance Regimens in Renal Transplants in Brazil: Survival Analysis from 2000 to 2004
Annals of Pharmacotherapy, 12/16/09
'Party pill' drugs - BZP and TFMPP
New Zealand Medical Journal, 12/14/09
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Dienogest: a new therapeutic agent for the treatment of endometriosis *TEST*
Women's Health, 12/17/09
Investigational drugs for allergic rhinitis
Expert Opinion on Investigational Drugs, 12/17/09
Predicting short term response to anti-inflammatory therapy in young children with asthma
Current Medical Research and Opinion, 12/17/09

See Latest Articles